Description: Doseology Sciences Inc. intends to operate as a wellness company in Canada. The company focuses on the development and sale of functional mushroom products, including tinctures and capsules; development of an indoor cannabis nursery for the cultivation and sale of cannabis mothers and clones; establishment and operation of a clinic to offer treatment using psychedelic compounds in Portland, Oregon; and conducting research and development on psychedelic compounds for scientific purposes. Doseology Sciences Inc. was incorporated in 2019 and is headquartered in Vernon, Canada.
Home Page: doseology.com
9-3151 Lakeshore Road
Kelowna,
BC
V1W 3S9
Canada
Phone:
604-908-3095
Officers
| Name | Title |
|---|---|
| Mr. Daniel Vice | Co-Founder & Director |
| Mr. Christopher P. Cherry | Interim CEO & CFO |
| Ms. Lindsay Hamelin | Corporate Secretary |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9104 |
| Price-to-Sales TTM: | 13.0248 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |